BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32179210)

  • 21. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia.
    Okamoto N; Nakai T; Sakamoto K; Nagafusa Y; Higuchi T; Nishikawa T
    J ECT; 2010 Sep; 26(3):223-7. PubMed ID: 19935085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
    Anand A; Mathew SJ; Sanacora G; Murrough JW; Goes FS; Altinay M; Aloysi AS; Asghar-Ali AA; Barnett BS; Chang LC; Collins KA; Costi S; Iqbal S; Jha MK; Krishnan K; Malone DA; Nikayin S; Nissen SE; Ostroff RB; Reti IM; Wilkinson ST; Wolski K; Hu B
    N Engl J Med; 2023 Jun; 388(25):2315-2325. PubMed ID: 37224232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose ketamine does not improve the speed of recovery from depression in electroconvulsive therapy: a randomized controlled trial.
    Woolsey AJ; Nanji JA; Moreau C; Sivapalan S; Bourque SL; Ceccherini-Nelli A; Gragasin FS
    Braz J Psychiatry; 2022; 44(1):6-14. PubMed ID: 34076068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.
    Siegel JS; Palanca BJA; Ances BM; Kharasch ED; Schweiger JA; Yingling MD; Snyder AZ; Nicol GE; Lenze EJ; Farber NB
    Psychopharmacology (Berl); 2021 Apr; 238(4):1157-1169. PubMed ID: 33483802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.
    Jha MK; Wilkinson ST; Krishnan K; Collins KA; Sanacora G; Murrough J; Goes F; Altinay M; Aloysi A; Asghar-Ali A; Barnett B; Chang L; Costi S; Malone D; Nikayin S; Nissen SE; Ostroff R; Reti I; Wolski K; Wang D; Hu B; Mathew SJ; Anand A
    JAMA Netw Open; 2024 Jun; 7(6):e2417786. PubMed ID: 38916891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.
    Abdallah CG; Fasula M; Kelmendi B; Sanacora G; Ostroff R
    J ECT; 2012 Sep; 28(3):157-61. PubMed ID: 22847373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant Effects of Electroconvulsive Therapy Unrelated to the Brain's Functional Network Connectivity alterations at an Individual Level.
    Chen GD; Ji F; Li GY; Lyu BX; Hu W; Zhuo CJ
    Chin Med J (Engl); 2017 Feb; 130(4):414-419. PubMed ID: 28218214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient effects of multi-infusion ketamine augmentation on treatment-resistant depressive symptoms in patients with treatment-resistant bipolar depression - An open-label three-week pilot study.
    Zhuo C; Ji F; Tian H; Wang L; Jia F; Jiang D; Chen C; Zhou C; Lin X; Zhu J
    Brain Behav; 2020 Aug; 10(8):e01674. PubMed ID: 32621379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.
    Wade BSC; Hellemann G; Espinoza RT; Woods RP; Joshi SH; Redlich R; Jørgensen A; Abbott CC; Oedegaard KJ; McClintock SM; Oltedal L; Narr KL
    J ECT; 2020 Jun; 36(2):123-129. PubMed ID: 31464814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent administration of low dose ketamine can shorten the course of electroconvulsive therapy for depression and reduce complications: A randomized controlled trial.
    Dong J; Min S; Qiu H; Chen Q; Ren L
    Psychiatry Res; 2019 Nov; 281():112573. PubMed ID: 31586838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of ketamine, propofol, and dexmedetomidine for anesthesia in electroconvulsive therapy in treatment-resistant major depressive disorder patients: a double-blind randomized clinical trial.
    Modir H; Mahmoodiyeh B; Shayganfard M; Abdus A; Almasi-Hashiani A
    Med Gas Res; 2023; 13(3):112-117. PubMed ID: 36571375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effect of intravenous anesthetics used for anesthesia during electroconvulsive therapy on the hemodynamic safety and the course of ECT.
    Wojdacz R; Święcicki Ł; Antosik-Wójcińska A
    Psychiatr Pol; 2017 Dec; 51(6):1039-1058. PubMed ID: 29432502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment escalation in patients not responding to pharmacotherapy, psychotherapy, and electro-convulsive therapy: experiences from a novel regimen using intravenous S-ketamine as add-on therapy in treatment-resistant depression.
    Kallmünzer B; Volbers B; Karthaus A; Tektas OY; Kornhuber J; Müller HH
    J Neural Transm (Vienna); 2016 May; 123(5):549-52. PubMed ID: 26721476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pramipexole and Electroconvulsive Therapy in Treatment-Resistant Depression.
    Gauthier C; Souaiby L; Advenier-Iakovlev E; Gaillard R
    Clin Neuropharmacol; 2017; 40(6):264-267. PubMed ID: 29059135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S -ketamine compared to etomidate during electroconvulsive therapy in major depression.
    Zavorotnyy M; Kluge I; Ahrens K; Wohltmann T; Köhnlein B; Dietsche P; Dannlowski U; Kircher T; Konrad C
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):803-813. PubMed ID: 28424861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electroconvulsive therapy in treatment resistant depression: What is new?].
    Kaliora SC
    Psychiatriki; 2021 Dec; 32(Supplement I):82-89. PubMed ID: 34990383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy of electroconvulsive therapy (ECT) plus agomelatine to ECT plus placebo in treatment-resistant depression.
    Lin CH; Yang WC; Chen CC; Cai WR
    Acta Psychiatr Scand; 2020 Aug; 142(2):121-131. PubMed ID: 32412097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy.
    Allen AP; Naughton M; Dowling J; Walsh A; O'Shea R; Shorten G; Scott L; McLoughlin DM; Cryan JF; Clarke G; Dinan TG
    J Psychiatr Res; 2018 May; 100():24-32. PubMed ID: 29475018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.